Patents Represented by Attorney George R. Beck
  • Patent number: 5304119
    Abstract: An instrument for injecting implants through animal hide is comprised of an injector having a tubular body divided into two adjacent segments with a hollow interior bore extending through the segments of the body. The second segment of the body has a generally tapering configuration as it extends to the distal end of the body and is formed as a pair of laterally adjacent tines that extend longitudinally from adjacent the first body segment to the distal end of the body. One of the tines has a larger lateral width than a second of the tines at laterally adjacent cross sections of the tines, and one tine has a terminal end at the distal end of the body for making incisions through animal hide when employing the instrument in injecting implants. A push rod having a longitudinal length at least equal to the longitudinal length of the body is inserted through the interior bore of the body pushing the implant before it.
    Type: Grant
    Filed: June 24, 1993
    Date of Patent: April 19, 1994
    Assignee: Monsanto Company
    Inventors: Stephen M. Balaban, Jonathan P. Smith
  • Patent number: 5232708
    Abstract: Solid dosage forms of bioactive materials for parenteral administration such as porcine or bovine somatotropin pellets intended for subcutaneous implantation to improve food production of farm animals are coated with polyvinyl alcohol to extend the release characteristics of the material. The polyvinyl alcohol preferably has a molecular weight of from about 20,000 to 100,000, a degree of hydrolysis of at least about 98%, and is applied from an aqueous solution by spray coating to form a continuous uniform covering of from about 3 to 25 ug PVA/mm.sup.2 surface area of pellet.
    Type: Grant
    Filed: May 21, 1992
    Date of Patent: August 3, 1993
    Assignee: Monsanto Company
    Inventors: Ernesto J. Castillo, Kenneth E. Eigenberg, Kanaiyalal R. Patel, Milton J. Sabacky
  • Patent number: 5182302
    Abstract: The growth of milk-producing mammary parenchyma in a mammal can be significantly enhanced by administering to the mammal by intramammary infusion a substance having a mitogenic effect on mammary epithelial cells in said mammal. Good growth enhancement can be achieved using very small quantities of such substances, and in relatively short periods of time.
    Type: Grant
    Filed: June 28, 1991
    Date of Patent: January 26, 1993
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Michael F. McGrath
  • Patent number: 5156670
    Abstract: Fully substituted pyridines having a cyclic alkylidene substituent, useful as herbicides, compositions and methods of use thereof.
    Type: Grant
    Filed: June 3, 1991
    Date of Patent: October 20, 1992
    Assignee: Monsanto Company
    Inventors: Len F. Lee, Kathleen K. Smith, Karey A. Van Sant
  • Patent number: 5141922
    Abstract: A method for preparing polypeptides in bacteria with an alanine rather than a methionine at the N-terminus. The DNA sequence expressed has an alanine codon immediately following from at least one methionine codon, and allows for the expression of polypeptides having the amino acid sequence essentially the same as such naturally occurring eucaryotic protein as various bovine and porcine somatotropin species. In another important embodiment, the invention provides a class of compositions comprising certain valine-containing somatropin species which increase milk production in lactating mammals to a significantly greater extent than otherwise-identical leucine somatotropin species.
    Type: Grant
    Filed: July 12, 1991
    Date of Patent: August 25, 1992
    Assignee: Monsanto Company
    Inventor: Gwen G. Krivi
  • Patent number: 5130300
    Abstract: The growth of milk-producing mammary parenchyma in a mammal can be significantly enhanced by administering to the mammal by intramammary infusion a substance having a mitogenic effect on mammary epithelial cells in said mammal. Good growth enhancement can be achieved using very small quantities of such substances, and in relatively short periods of time.
    Type: Grant
    Filed: March 14, 1990
    Date of Patent: July 14, 1992
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Michael F. McGrath
  • Patent number: 5130299
    Abstract: The growth of milk-producing mammary parenchyma in a mammal can be significantly enhanced by administering to the mammal by intramammary infusion a substance having a mitogenic effect on mammary epithelial cells in said mammal. Good growth enhancement can be achieved using very small quantities of such substances, and in relatively short periods of time.
    Type: Grant
    Filed: June 28, 1991
    Date of Patent: July 14, 1992
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Michael F. McGrath
  • Patent number: 5093347
    Abstract: Novel 3-difluoromethyl-1-methyl-N-(substituted-indane-4-yl)pyrazole-4-carboxamid es useful as fungicides, particularly effective in alleviating infections in diseased plants.
    Type: Grant
    Filed: July 3, 1991
    Date of Patent: March 3, 1992
    Assignee: Monsanto Company
    Inventors: Matthew J. Graneto, Wendell G. Phillips
  • Patent number: 5086041
    Abstract: Prolonged parenteral release of a bioactive polypeptide at desirably effective levels can be achieved by administering compositions in which the polypeptide is present in a biocompatible oil in an unusually high proportion such as at least about 10% by weight. Also disclosed are certain metal-associated somatotropins that are useful for prolonged parenteral release of such somatotropins.
    Type: Grant
    Filed: August 16, 1990
    Date of Patent: February 4, 1992
    Assignee: Monsanto Company
    Inventor: James W. Mitchell
  • Patent number: 5084384
    Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamB or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.
    Type: Grant
    Filed: May 10, 1990
    Date of Patent: January 28, 1992
    Assignee: Monsanto Company
    Inventors: Edith Wong, Michael L. Bittner
  • Patent number: 5059586
    Abstract: The growth of milk-producing mammary parenchyma in a mammal can be significantly enhanced by administering to the mammal by intramammary infusion a substance having a mitogenic effect on mammary epithelial cells in said mammal. Good growth enhancement can be achieved using very small quantities of such substances, and in relatively short periods of time.
    Type: Grant
    Filed: September 2, 1987
    Date of Patent: October 22, 1991
    Assignee: Monsanto Company
    Inventors: Robert J. Collier, Michael F. McGrath
  • Patent number: 5037806
    Abstract: A method for preparing polypeptides in bacteria with an alanine rather than a methionine at the N-terminus. The DNA sequence expressed has an alanine codon immediately following from at least one methionine codon, and allows for the expression of polypeptides having the amino acid sequence essentially the same as such naturally occurring eucaryotic protein as various bovine and porcine somatotropin species. In another important embodiment, the invention provides a class of compositions comprising certain valine-containing somatropin species which increase milk production in lactating mammals to a significantly greater extent than otherwise-identical leucine somatotropin species.
    Type: Grant
    Filed: February 4, 1986
    Date of Patent: August 6, 1991
    Assignee: Monsanto Company
    Inventor: Gwen G. Krivi
  • Patent number: 5013713
    Abstract: Prolonged parenteral release of a bioactive polypeptide at desirably effective levels can be achieved using novel compositions in which the polypeptide is present in a biocompatible oil in an unusually high proportion such as at least about 10% by weight. Also disclosed are certain metal-associated somatotropins that are useful for prolonged parenteral release of such somatotropins.
    Type: Grant
    Filed: September 29, 1989
    Date of Patent: May 7, 1991
    Assignee: Monsanto Company
    Inventor: James W. Mitchell
  • Patent number: 4985404
    Abstract: Prolonged parenteral release of a bioactive polypeptide at desirably effective levels can be achieved using novel compositions in which the polypeptide is present in a biocompatible oil in an unusually high proportion such as at least about 10% by weight. Also disclosed are certain metal-associated somatotropins that are useful for prolonged parenteral release of such somatotropins.
    Type: Grant
    Filed: June 29, 1988
    Date of Patent: January 15, 1991
    Assignee: Monsanto Company
    Inventor: James W. Mitchell
  • Patent number: 4981956
    Abstract: This invention relates to novel peptides having utility for promotion of growth and/or lactation in animals, to processes and DNA useful in production of such peptides, and to methods utilizing such peptides to promote growth or lactation in animals. In some embodiments, the invention is directed to peptides having bovine IGF-II biological activity, to production of such peptides, and to their use in effecting proliferation of certain cells (e.g. mammary epithelial or muscle) or in enhancing lactation in cattle or other animals.
    Type: Grant
    Filed: October 6, 1988
    Date of Patent: January 1, 1991
    Assignee: Monsanto Company
    Inventors: Brent R. Larsen, Ned R. Siegel, Claire E. Kotts, Michael F. McGrath, Sharon D. Ogden, Gwen G. Krivi, John C. Minnerly
  • Patent number: 4964896
    Abstract: This invention relates to compounds of the formula: ##STR1## wherein R.sub.1 is an optionally substituted alkyl or alkenyl group; at least one of R.sub.2, R.sub.5 and R.sub.6 is ##STR2## wherein (1) when R.sub.2 is ##STR3## R.sub.5 is a hydrogen atom, an alkyl group or a halogen atom and R.sub.6 is a hydrogen atom or an alkyl group,(2) when R.sub.5 is ##STR4## R.sub.2 is an alkyl group and R.sub.6 is a hydrogen atom or an alkyl group,(3) when R.sub.6 is ##STR5## R.sub.2 is an optionally substituted (C.sub.1 -C.sub.6) alkyl or a (C.sub.3 -C.sub.6) alkenyl group and R.sub.5 is a hydrogen atom, a (C.sub.1 -C.sub.6) alkyl group or a halogen atom, and(4) when R.sub.2 and R.sub.6 are both independently ##STR6## R.sub.5 is hydrogen atom or an alkyl group; Y is a hydrogen atom or an alkyl group; X is a hydrogen atom, a halogen atom, a trihalomethyl group and the like; and n is an integer from 1 to 3; or the agronomically acceptable alkali metal or acid addition salts thereof.
    Type: Grant
    Filed: August 15, 1988
    Date of Patent: October 23, 1990
    Assignee: Monsanto Company
    Inventor: Glenn R. Carlson
  • Patent number: 4964895
    Abstract: The present invention relates to certain novel substituted 3-(4-nitrophenoxy)pyrazoles and their use as herbicides.
    Type: Grant
    Filed: January 30, 1990
    Date of Patent: October 23, 1990
    Assignee: Monsanto Company
    Inventors: Kurt Moedritzer, Michael D. Rogers
  • Patent number: 4962199
    Abstract: The present invention relates to a process for making substituted 4-oxo-1,4-dihydropyridazines by reacting a 2-phenylhyrazono-3-oxoglutarate with an organic acid halide in the presence of magnesium halide.
    Type: Grant
    Filed: February 1, 1990
    Date of Patent: October 9, 1990
    Assignee: Monsanto Company
    Inventor: Gopi Yalamanchili
  • Patent number: 4863736
    Abstract: Provided is a shaped article adapted for parenteral implantation, to obtain prolonged administration of a somatotropin to an animal comprising an effective dose of a solid somatotropin, which is essentially binder-free, essentially matrix-free and has at least one uncoated release surface.
    Type: Grant
    Filed: February 3, 1988
    Date of Patent: September 5, 1989
    Assignee: Monsanto Company
    Inventors: Michael J. Azain, Kenneth E. Eigenberg, Thomas R. Kasser, M. Jerome Sabacky
  • Patent number: 4861868
    Abstract: A method for preparing polypeptides in bacteria with an alanine rather than a methionine at the N-terminus. The DNA sequence expressed has an alanine codon immediately following from one to about three contiguous methionine codons including a translation start signal and allows for the expression of polypeptides having the amino acid sequence of, for example, naturally occurring eucaryotic proteins such as various bovine and porcine somatotropin species.
    Type: Grant
    Filed: February 22, 1985
    Date of Patent: August 29, 1989
    Assignee: Monsanto Company
    Inventor: Gwen G. Krivi